AKTX vs HUM · $17.2M cap vs P/E 39, rev $129.66B
Akari Therapeutics PLC (AKTX) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
AKTX does not have a complete income-statement cache yet.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
AKTX currently screens at market cap $17.2M. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the AKTX and HUM stock pages for the full models.
Not investment advice.